ICD-10-CM Billable Code

D30.2

Benign neoplasm of ureter

Clinical Classification Guidelines

Excludes Type 1

  • benign neoplasm of ureteric orifice of bladder (D30.3)

Medical Intelligence & Overview

A benign neoplasm of the ureter refers to a non-cancerous growth that develops in the ureter, the tube responsible for transporting urine from the kidneys to the bladder. Although these growths are not malignant, their presence can cause various health concerns, mainly related to urinary flow and potential obstruction. Understanding this condition involves recognizing its causes, symptoms, diagnosis methods, and treatment options.

Causes & Symptoms

Clinical Causes: Genetic factors that may predispose individuals to benign tumor growths Chronic inflammation or irritation of the ureter Previous infections affecting the urinary tract Unidentified environmental exposures or factors Rarely, as a result of benign tumors originating from other parts of the urinary system and spreading to the ureter

Key Symptoms: Intermittent or ongoing pain in the side or lower back Hematuria, or blood in the urine Urinary retention or difficulty passing urine Frequent urinary infections Unexplained urinary urgency Feeling of incomplete bladder emptying

Diagnostic & Treatment

Diagnosis Path: Diagnosing a benign neoplasm of the ureter involves a combination of clinical evaluation and imaging tests. Healthcare providers may employ the following methods: - **Urinalysis:** To detect blood, infection, or other abnormalities in the urine. - **Imaging Studies:** - **Ultrasound:** To observe the urinary tract and identify any obstructions or growths. - **Computed Tomography (CT) Urography:** Offers detailed images of the urinary system and helps locate the tumor. - **Magnetic Resonance Urography (MRU):** Used for detailed soft tissue imaging. - **Ureteroscopy:** A procedure where a small camera is inserted into the ureter to directly visualize and sometimes biopsy the growth. - **Biopsy:** Obtaining tissue samples to confirm the benign nature of the tumor.

Treatment Protocols: Treatment options focus primarily on removing or managing the benign tumor to alleviate symptoms and prevent complications. These procedures include: - **Endoscopic Resection:** Minimally invasive removal of the tumor via ureteroscopy, suitable for accessible growths. - **Surgical Excision:** When endoscopic methods are insufficient, open or laparoscopic surgery may be needed to remove larger or difficult-to-access tumors. - **Monitoring:** In some cases where the tumor is small and asymptomatic, regular observation with imaging may be recommended. - **Addressing Underlying Causes:** Managing any infections or irritant factors contributing to tumor development. Follow-up care is essential to monitor for recurrence or complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D30.2 a billable ICD-10 code?
Yes, D30.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D30.2?
Clinical documentation must specify the nature of Benign neoplasm of ureter and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

neoplasm ureter